Standout Papers

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial... 2024 202639
  1. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial (2024)
    Thierry Conroy, Florence Castan et al. Annals of Oncology

Immediate Impact

55 standout
Sub-graph 1 of 24

Citing Papers

Smart hydrogel: A new platform for cancer therapy
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
2 intermediate papers

Works of Florence Castan being referenced

Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
2018
Quantification of HER Expression and Dimerization in Patients’ Tumor Samples Using Time-Resolved Förster Resonance Energy Transfer
2012

Author Peers

Author Last Decade Papers Cites
Florence Castan 484 204 297 36 666
J.P. Gérard 464 211 486 44 831
Wei‐Han Hu 254 238 193 41 709
Yongrui Bai 268 234 183 48 706
Liming Sheng 473 274 188 44 764
Jennifer A. Dorth 331 259 229 60 779
D. Latz 254 206 221 31 585
R Keiling 356 101 152 37 677
Nadia Pasinetti 263 364 149 38 786
Eric Tonndorf‐Martini 308 174 330 20 633
Stephanie Markovina 237 148 277 55 799

All Works

Loading papers...

Rankless by CCL
2026